[
    [
        {
            "time": "",
            "original_text": "一周药闻丨甘李药业门冬胰岛素获批上市 Moderna新冠疫苗获FDA快速通道资格",
            "features": {
                "keywords": [
                    "甘李药业",
                    "门冬胰岛素",
                    "获批上市",
                    "Moderna",
                    "新冠疫苗",
                    "FDA快速通道"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "一周药闻丨甘李药业门冬胰岛素获批上市 Moderna新冠疫苗获FDA快速通道资格",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]